News|Articles|December 13, 2023
DEVELOPICK™: High-throughput developability assessment to enable efficient formulation development
Author(s)Samsung Biologics
Explore how Samsung Biologics’ DEVELOPICK™ can help mitigate development risk and identify candidates with the best potential for advancement to IND and beyond
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Using A Streamlined Workflow to Identify Particulates in Biologic Drugs
2
How 3D-Printed Tablets Can Optimize IgA Nephropathy Treatment
3
AI-Powered Digital Twins Achieve High Accuracy in Human Lung Function Forecasting
4
Defining An Agitation Model for Early-Stage, High Concentration Biologics Formulation Development
5
